|
|
|
|
|
|
|
|
|
|
Join our webinar on October 22, 2026, at 11 AM ET to learn how to successfully execute adaptive trials. We will explore key impacts on sites, data, technology, supply, and teams. Don't let adaptation turn into disruption—register today to secure your spot! Registration is free.
|
|
|
|
|
|
|
|
The Rare Trials Summit Wants To Produce More Than Conversation
|
|
From The Editor | By Dan Schell, Chief Editor, Clinical Leader
|
The Rare Trials Summit returns to Boston this September with a mission that extends beyond traditional conference presentations. Through interactive workshops and working groups focused on regulatory guidance and pediatric trials, organizers hope to produce practical solutions that help advance rare disease clinical research.
|
|
|
|
|
|
To Take On Transverse Myelitis, Researchers Must First Address Heterogeneity And Misguided Outcome Measures
|
|
Guest Column | A conversation between Irena Dujmovic Basuroski, MD, Ph.D., UNC School of Medicine Department of Neurology, and Clinical Leader Executive Editor Abby Proch
|
UNC researcher Irena Dujmovic Basuroski, MD, Ph.D., discusses why transverse myelitis remains difficult to study, how multicenter collaboration and adaptive trial designs may help, and why better clinical, patient-reported, and biomarker-based measures are essential to advancing treatment.
|
|
|
|
|
|
|
|
|
|
Whole Health In Action: Real-World Examples Of Better Outcomes
|
|
Video | ISPOR—The Professional Society for Health Economics and Outcomes Research
|
Whole health looks beyond traditional care by addressing food access, environment, and lived experiences—leading to healthier communities and more holistic outcomes.
|
|
|
|
|
|
|
|
Beyond The Benchmark: Innovative Trial Designs Transform Research
|
|
White Paper | By Meg Hooton, Murray Aitken and Keith McDonald, IQVIA Biotech
|
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
|
|
|
|
|
|
Unique IRT Considerations For Personalized Medicine Trials
|
|
White Paper | Almac Clinical Technologies
|
The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
|
|
|
|
|
|
|
|
|
|
|
| Connect With Clinical Leader: |
|
|
|
|
